Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Massachusetts General Hospital
Study ID
NCT04916210
Status
Recruiting

Conditions

  • Dementia, Vascular
  • Intracerebral Hemorrhage
  • Ischemic Stroke
  • Mild Cognitive Impairment
  • Subarachnoid Hemorrhage
  • Vascular Cognitive Impairment

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities that significantly affects daily functioning) after their stroke so that future treatments may be developed to improve outcomes in stroke patients. For this study, a "stroke" is defined as either (1) an acute ischemic stroke (AIS, or blood clot in the brain), (2) an intracerebral hemorrhage (ICH, or bleeding in the brain), (3) or an aneurysmal subarachnoid hemorrhage (aSAH, or bleeding around the brain caused by an abnormal bulge in a blood vessel that bursts). The investigators hypothesize that: 1. The size, type and location of the stroke play an important role in recovery of thinking and memory abilities after stroke, and pre-existing indicators of brain health further determine the extent of this recovery. 2. Specific stroke events occurring in individuals with underlying genetic or biological risk factors can cause further declines in brain heath, leading to changes in thinking and memory abilities after stroke. 3. Studying thinking and memory alongside brain imaging and blood samples in patients who have had a stroke allows for earlier identification of declining brain health and development of individualized treatment plans to improve patient outcomes in the future.

Key Dates

Start date
Mar 5, 2021
Status verified
Oct 2025
Primary completion
Aug 31, 2026
Completion
Aug 31, 2026

Study Design

Enrollment
8,000 participants (estimated)

Primary Outcome Measure

Change in post-stroke cognitive impairment and dementia (PSCID) diagnosis status [ Time Frame: Baseline to 48 months post-index stroke ]

Central Contacts

Locations (31)

FacilityCityStateZIPSite coordinators
Barrow Neurological InstitutePhoenixArizona85013
Supreet Kaur, MD
Supreet Kaur, MD (PRINCIPAL_INVESTIGATOR)
Cedars Sinai Medical CenterLos AngelesCalifornia90048
Shlee Song, MD
Shlee Song, MD (PRINCIPAL_INVESTIGATOR)
Kaiser Permanente Los Angeles Medical CenterLos AngelesCalifornia90027
Navdeep Sangha, MD
Pamela Cheng, DO
Navdeep Sangha, MD (PRINCIPAL_INVESTIGATOR)
Pamela Cheng, DO (PRINCIPAL_INVESTIGATOR)
University of California Los AngelesLos AngelesCalifornia90095
Katherine Mun, MD
Katherine Mun, MD (PRINCIPAL_INVESTIGATOR)
University of California San DiegoSan DiegoCalifornia92037
Brett Meyer, MD
Brett Meyer, MD (PRINCIPAL_INVESTIGATOR)
University of ColoradoDenverColorado80045
Jennifer Simpson, MD
Jennifer Simpson, MD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicJacksonvilleFlorida32224
Michelle Lin, MD, MPH
Michelle Lin, MD, MPH (PRINCIPAL_INVESTIGATOR)
University of Miami Health SystemMiamiFlorida33125
Nicole Sur, MD
Nicole Sur, MD (PRINCIPAL_INVESTIGATOR)
The University of Chicago Medical CenterChicagoIllinois60637
Karen Orjuela, MD, MS
Karen Orjuela, MD, MS (PRINCIPAL_INVESTIGATOR)
Indiana UniversityIndianapolisIndiana46202
Jason Mackey, MD
Jason Mackey, MD (PRINCIPAL_INVESTIGATOR)
University of IowaIowa CityIowa52242-
University of Maryland Medical CenterBaltimoreMaryland21201
Gunjan Parikh, MD
Gunjan Parikh, MD (PRINCIPAL_INVESTIGATOR)
Boston Medical CenterBostonMassachusetts02118
Hugo Aparicio, MD, MPH
Hugo Aparicio, MD, MPH (PRINCIPAL_INVESTIGATOR)
Massachusetts General HospitalBostonMassachusetts02114
Natalia Rost, MD
Natalia Rost, MD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109-
University of Minnesota HealthMinneapolisMinnesota55455
Kamakshi Lakshminarayan, MD, PhD, MS
Kamakshi Lakshminarayan, MD, PhD, MS (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55902
Eugene Scharf, MD
Eugene Scharf, MD (PRINCIPAL_INVESTIGATOR)
University of Mississippi Medical CenterJacksonMississippi39216
Shreyas Gangadhara, MD
Shreyas Gangadhara, MD (PRINCIPAL_INVESTIGATOR)
Icahn School of Medicine at Mount SinaiNew YorkNew York10029
Michael Waters, MD, PhD
Michael Waters, MD, PhD (PRINCIPAL_INVESTIGATOR)
Montefiore Medical CenterThe BronxNew York10467
Daniel Antoniello, MD
Daniel Antoniello, MD (PRINCIPAL_INVESTIGATOR)
Duke University Medical CenterDurhamNorth Carolina27708
Nada El Husseini, MD, MHS
Nada El Husseini, MD, MHS (PRINCIPAL_INVESTIGATOR)
Wake Forest Baptist HealthWinston-SalemNorth Carolina27157-
University of CincinnatiCincinnatiOhio45219
Stacie Demel, DO, PhD
Stacie Demel, DO, PhD (PRINCIPAL_INVESTIGATOR)
The Hospital of the University of PennsylvaniaPhiladelphiaPennsylvania19104
Kelly Sloane, MD
Kelly Sloane, MD (PRINCIPAL_INVESTIGATOR)
Methodist University HospitalMemphisTennessee38104
Balaji Krishnaiah, MD
Balaji Krishnaiah, MD (PRINCIPAL_INVESTIGATOR)
Houston Methodist Research InstituteHoustonTexas77030
Rajan Gadhia, MD
Rajan Gadhia, MD (PRINCIPAL_INVESTIGATOR)
UTHealthHoustonTexas77030
Sean Savitz, MD
Seema Aggarwal, PhD, APRN, AGNP-C
Sean Savitz, MD (PRINCIPAL_INVESTIGATOR)
Seema Aggarwal, PhD, APRN, AGNP-C (PRINCIPAL_INVESTIGATOR)
University of Texas Health Science Center at San AntonioSan AntonioTexas78229
Andrew Slusher, MD
Andrew Slusher, MD (PRINCIPAL_INVESTIGATOR)
University of UtahSalt Lake CityUtah84132
Jennifer Majersik, MD, MS
Jennifer Majersik, MD, MS (PRINCIPAL_INVESTIGATOR)
University of VirginiaCharlottesvilleVirginia22903
Bradford Worrall, MD
Bradford Worrall, MD (PRINCIPAL_INVESTIGATOR)
University of Washington, Harborview Medical CenterSeattleWashington98104
Rizwan Kalani, MD
Rizwan Kalani, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

By condition

Related Studies